|
AK3L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71090000000707E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47269999994926E-06 |
| Normal-vs-Stage2 |
1.415160E-04 |
| Normal-vs-Stage3 |
1.54548999999893E-05 |
| Normal-vs-Stage4 |
2.30780000000097E-05 |
| Stage1-vs-Stage2 |
2.333000E-01 |
| Stage1-vs-Stage3 |
3.023600E-01 |
| Stage1-vs-Stage4 |
3.420800E-01 |
| Stage2-vs-Stage3 |
5.653200E-01 |
| Stage2-vs-Stage4 |
7.403400E-01 |
| Stage3-vs-Stage4 |
7.812800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48749999998132E-06 |
| Normal-vs-AfricanAmerican |
4.98360000045217E-07 |
| Normal-vs-Asian |
4.011600E-04 |
| Caucasian-vs-AfricanAmerican |
4.796500E-03 |
| Caucasian-vs-Asian |
7.076600E-01 |
| AfricanAmerican-vs-Asian |
3.178400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.29459999997916E-06 |
| Normal-vs-Female |
4.2259000000433E-06 |
| Male-vs-Female |
1.321640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.04989999996741E-06 |
| Normal-vs-Extreme_Weight |
5.49400000049438E-07 |
| Normal-vs-Obese |
3.03940000001557E-06 |
| Normal-vs-Extreme_Obese |
1.556700E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.463040E-01 |
| Normal_Weight-vs-Obese |
7.665400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.889800E-01 |
| Extreme_Weight-vs-Obese |
7.075900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.805950E-01 |
| Obese-vs-Extreme_Obese |
5.529400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.62250000004904E-06 |
| Normal-vs-Age(41-60Yrs) |
1.30560000000113E-06 |
| Normal-vs-Age(61-80Yrs) |
2.00350000001404E-06 |
| Normal-vs-Age(81-100Yrs) |
2.14889999999857E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.316600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.457200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.665000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.784400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.313600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.772200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.51700000023448E-07 |
| Normal-VS-Type2 PRCC |
3.53980000000753E-05 |
| Normal-VS-KIRP CIMP |
1.419760E-04 |
| Normal-VS-Unclassified PRCC |
1.72769999995381E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.057900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.958600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.043200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.053000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.901600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.864300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.65474999999082E-05 |
| Normal-vs-N1 |
3.62219999999747E-05 |
| Normal-vs-N2 |
9.78430000000419E-05 |
| N0-vs-N1 |
6.263400E-01 |
| N0-vs-N2 |
9.945600E-01 |
| N1-vs-N2 |
7.893000E-01 |
|
|
